Disfunción sexual masculina

Barra lateral del artículo

PDF
Publicado: 10-12-2005
DOI: https://doi.org/10.51987/Rev.Hosp.Ital.B.Aires.v25i2.1192

Contenido principal del artículo

Guillermo Gueglio
Servicio de Urología. Hospital Italiano de Buenos Aires

Resumen

.

Downloads

Download data is not yet available.

Detalles del artículo

Número

Vol. 25 Núm. 2 (2005): Revista del Hospital Italiano de Buenos Aires

Sección

Revisión
Creative Commons License

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.

Cómo citar

1.
Gueglio G. Disfunción sexual masculina. Rev Hosp Ital B.Aires [Internet]. 2005 Dec. 10 [cited 2026 Apr. 26];25(2):58-64. Available from: https://ojs.hospitalitaliano.org.ar/index.php/revistahi/article/view/1192

Referencias

Morley JE. Impotence. Am J Med 1986; 80:897-905. DOI: https://doi.org/10.1016/0002-9343(86)90635-2

Ignarro LJ, Bush PA, Buga GM y col. Nitricoxide and cyclic GMP formation upon electricalfield stimulation causes relaxation of corpuscavernosal smooth muscle. Biochem BiophysRes Commun 1990; 170: 843-850. DOI: https://doi.org/10.1016/0006-291X(90)92168-Y

Zeller LF, Mazza ON. Mecanismos neuro-fisiológicos que regulan la erección. En: Tra-tamiento farmacológico de la disfuncióneréctil. Buenos Aires: Editorial Panamerica-na; 1997. p. 13.

Christ, GH; Brink, PR; Melman, A et al.: Therole of gap junctions and ion channels signalsin human corpus cavernosum smooth muscle.Int J Impot Res, 5: 77, 1993.

Christ GH. K+ channels and gap junctions inthe modulation of corporal smooth muscle tone.Drug News Perspect 2000; 13: 28-36.

Karacan I. Clinical value of nocturnalerection in the prognosis and diagnosis ofimpotence. Med Aspects Hum Sex 1970; 4: 27.

Lue TF, Hricak H, Marich KW y col.Vasculogenic impotence evaluated by highresolution ultrasonography and pulsedDoppler spectrum analysis. Radiology 1985;155: 777-781. DOI: https://doi.org/10.1148/radiology.155.3.3890009

Vardi YV, Volos MV, Sprecher ES y col.Response of auditory induced P300 EEG waveto sexual and non-sexual video clips—a newmethod for the evaluation of sexual interest. JSex Med 2004; 1: 44.

Meuleman E, Broderick G, Meng Tan H ycol. Clinical evaluation and the Doctor-Patientdialogue. En: Erectile Dysfunction. HealthPublication; 2000. p. 117.

Christ GJ. The penis as a vascular organ:The importance of corporal smooth muscle tonein the control of erection. Urol Clin North Am1995; 22: 727-745. DOI: https://doi.org/10.1016/S0094-0143(21)00692-3

Ross R. Is lifestyle modification anefficacious treatment strategy for endothelialfunction and ED?. J Sex Med 2004; 1(suppl.):3. DOI: https://doi.org/10.1111/j.1743-6109.2004.04051_3.x

Esposito K. Effect of lifestyle changes onerectile dysfunction in obese men. JAMA 2004;291: 2978- 2984. DOI: https://doi.org/10.1001/jama.291.24.2978

Gueglio G. Manejo del paciente norespondedor a la medicación oral. CongresoArgentino de Urología. Rosario, 2004.

Paick SH, Wessells H. Melanocortinreceptors and penile erection: from bench tobedside. International Society for Sexual andImpotence Research Newsbulletin Nro. 13, p12, 2004.

Clinton Webb R. Ying-Yang of corporalsmooth muscle control. J Sex Med 2004;1(suppl.): 1. DOI: https://doi.org/10.1111/j.1743-6109.2004.04051_1.x

Mc Vary KT, Polepalle S, Riggi S y col.Topical prostaglandin E1 SEPA gel for thetreatment of erectile dysfunction. J Urol 1999;162(3pt1): 726-730. DOI: https://doi.org/10.1097/00005392-199909010-00025

Melman A, Christ GJ. Integrative erectilebiology. Urol Clin North Am 2001; 28: 217-231 DOI: https://doi.org/10.1016/S0094-0143(05)70133-6

Melman A, Bar-Chama N, Christ GJ y col.The first phase in human gene transfer trial:ion channel therapy for the treatment of ED-preliminary results. J Sex Med 2004; 1(suppl.): 14. DOI: https://doi.org/10.1111/j.1743-6109.2004.04051_13.x

Metz ME, Pryor JL, Nesvacil LJ y col.Premature ejaculation: a psychophysiologicalreview. J Sex Marital Ther 1997; 23(1): 3. DOI: https://doi.org/10.1080/00926239708404413

Hendry WF, Althof GS, Benson y col. Maleorgasmic and ejaculatory disorders. En: ErectileDysfunction. Health Publication; 2000. p. 479.

Waldinger MD. The neurobiologicalapproach to premature ejaculation (review). JUrol, 168: 2359, 2002. DOI: https://doi.org/10.1016/S0022-5347(05)64146-8

Waldinger MD, Hengeveld MW,Zwinderman AH. Ejaculation-retardingproperties of paroxetine in patients withprimary premature ejaculation: a doubleblind, randomized, dose-response study. BrJ Urol 1997; 79: 592-595. DOI: https://doi.org/10.1046/j.1464-410X.1997.00102.x

Berkovitch M, Keresteci AG, Koren G.Efficacy of prilocaine-lidocaine cream in thetreatment of premature ejaculation. J Urol 1995;154: 1360-1361. DOI: https://doi.org/10.1016/S0022-5347(01)66861-7

Masters WH, Johnson VE. Human sexualinadequacy. Boston: Little Brown; 1970.

Eaton H. Clomipramin (Anafranil) in thetreatment of premature ejaculation. Int Med Res1973; 1: 432. DOI: https://doi.org/10.1177/030006057300100531

Waldinger MD, Hengeveld MW,Zwinderman AH. Paroxetine treatment ofpremature ejaculation: a double blind,randomized, placebo controlled study. Am JPsychiatry 1994; 151: 1377-1379. DOI: https://doi.org/10.1176/ajp.151.9.1377

Tullii RE, Di Iorio JM, Vaccari R y col.Neurectomy: New therapeutic technique forpremature ejaculation. Int J Impotence Res1992; 4(suppl.2).

Henry R, Morales A. Topical lidocaine-prilocaine spray for the treatment of prematureejaculation: a proof of concept study. Int JImpotence Res 2003; 15: 277-286 DOI: https://doi.org/10.1038/sj.ijir.3901011

Artículos más leídos del mismo autor/a